Please share the applicable regulations and/or guidance documents from the US FDA and ROW regarding the required retention period for clinical trial specimens such as blood, urine, etc. in support of an IND or NDA/BLA/MAA.
------------------------------
Aldwin Aldana
Director, Clinical QA and GxP Compliance
Cambridge MA
United States
------------------------------